Oxidatively Modified Proteins in the Serous Subtype of Ovarian Carcinoma

被引:8
|
作者
Mehrabi, Sharifeh [1 ]
Partridge, Edward E. [2 ]
Seffens, William [3 ]
Yao, Xuebiao [3 ]
Aikhionbare, Felix O. [1 ]
机构
[1] Morehouse Sch Med, Dept Med, Atlanta, GA 30310 USA
[2] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35249 USA
[3] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA
关键词
CHRONIC INFLAMMATION; EPITHELIAL-CELLS; CARBONYL CONTENT; FREE-RADICALS; CANCER RISK; STRESS; DNA; PROTEOLYSIS; RESPONSES; OVULATION;
D O I
10.1155/2014/585083
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Serous subtype of ovarian cancer is considered to originate from fallopian epithelium mucosa that has been exposed to physiological changes resulting from ovulation. Ovulation influences an increased in inflammation of epithelial ovarian cells as results of constant exposure of cells to ROS. The imbalance between ROS and antioxidant capacities, as well as a disruption of redox signaling, causes a wide range of damage to DNA, proteins, and lipids. This study applied spectrophotometric, dinitrophenylhydrazone ( DNPH) assay, two-dimensional gel electrophoresis, and Western blot analyses to assess the levels of oxidatively modified proteins in 100 primary serous epithelial ovarian carcinoma and normal/surrounding tissues. These samples were obtained from 56 Caucasian and 44 African-American patients within the age range of 61 +/- 10 years. Analyses showed that the levels of reactive protein carbonyl groups increased as stages progressed to malignancy. Additionally, the levels of protein carbonyls in serous ovarian carcinoma among African Americans are 40% (P < 0.05) higher relative to Caucasian at similar advanced stages. Results suggest that oxidative stress is involved in the modification of carbonyl protein groups, leading to increased aggressiveness of epithelial ovarian tumors and may contribute to the disease's invasiveness among African Americans.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Oxidatively modified proteins as plasma biomarkers in breast cancer
    Jin, Hongjun
    Daly, Don S.
    Marks, Jeffrey R.
    Zangar, Richard C.
    CANCER BIOMARKERS, 2013, 13 (03) : 193 - 200
  • [22] Calculator for ovarian carcinoma subtype prediction
    Kalloger, Steve E.
    Koebel, Martin
    Leung, Samuel
    Mehl, Erika
    Gao, Dongxia
    Marcon, Krista M.
    Chow, Christine
    Clarke, Blaise A.
    Huntsman, David G.
    Gilks, C. Blake
    MODERN PATHOLOGY, 2011, 24 (04) : 512 - 521
  • [23] The Ovarian Stroma and Endometrial Carcinoma Subtype
    Kostopoulou, E.
    Angelidou, S.
    Tziastoudi, E.
    Papathanasiou, A.
    Tatsiou, Z.
    Crum, C. P.
    Koukoulis, G.
    MODERN PATHOLOGY, 2009, 22 : 222A - 222A
  • [24] The Ovarian Stroma and Endometrial Carcinoma Subtype
    Kostopoulou, E.
    Angelidou, S.
    Tziastoudi, E.
    Papathanasiou, A.
    Tatsiou, Z.
    Crum, C. P.
    Koukoulis, G.
    LABORATORY INVESTIGATION, 2009, 89 : 222A - 222A
  • [25] The Claudin-Low Subtype of High-Grade Serous Ovarian Carcinoma Exhibits Stem Cell Features
    Romani, Chiara
    Capoferri, Davide
    Grillo, Elisabetta
    Silvestri, Marco
    Corsini, Michela
    Zanotti, Laura
    Todeschini, Paola
    Ravaggi, Antonella
    Bignotti, Eliana
    Odicino, Franco
    Sartori, Enrico
    Calza, Stefano
    Mitola, Stefania
    CANCERS, 2021, 13 (04) : 1 - 18
  • [26] Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)
    Talhouk, Aline
    George, Joshy
    Wang, Chen
    Budden, Timothy
    Tan, Tuan Zea
    Chiu, Derek S.
    Kommoss, Stefan
    Leong, Huei San
    Chen, Stephanie
    Intermaggio, Maria P.
    Gilks, Blake
    Nazeran, Tayyebeh M.
    Volchek, Mila
    Elatre, Wafaa
    Bentley, Rex C.
    Senz, Janine
    Lum, Amy
    Chow, Veronica
    Sudderuddin, Hanwei
    Mackenzie, Robertson
    Leong, Samuel C. Y.
    Liu, Geyi
    Johnson, Dustin
    Chen, Billy
    Alsop, Jennifer
    Banerjee, Susana N.
    Behrens, Sabine
    Bodelon, Clara
    Brand, Alison H.
    Brinton, Louise
    Carney, Michael E.
    Chiew, Yoke-Eng
    Cushing-Haugen, Kara L.
    Cybulski, Cezary
    Ennis, Darren
    Fereday, Sian
    Fortner, Renee T.
    Garcia-Donas, Jesus
    Gentry-Maharaj, Aleksandra
    Glasspool, Rosalind
    Goranova, Teodora
    Greene, Casey S.
    Haluska, Paul
    Harris, Holly R.
    Hendley, Joy
    Hernandez, Brenda Y.
    Herpel, Esther
    Jimenez-Linan, Mercedes
    Karpinskyj, Chloe
    Kaufmann, Scott H.
    CLINICAL CANCER RESEARCH, 2020, 26 (20) : 5411 - 5423
  • [27] Different expression of progesterone receptor between uterine serous carcinoma and ovarian serous carcinoma
    Matsuo, K.
    Eno, M. L.
    Abouzied, A. M.
    Im, D. D.
    Rosenshein, N. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [28] Relationship between age and menopausal status with the incident of epithelial ovarian cancer subtype high grade serous carcinoma
    Muthmainnah, Diniy Miftahul
    Muhammad, Syamel
    Susanti, Restu
    Harsby, Carmiyana Puja
    Yenita, Yenita
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A308 - A308
  • [29] Differential microrna expression in primary peritoneal serous carcinoma versus ovarian serous carcinoma
    O'Leary, J. J.
    Smyth, P.
    Laios, A.
    O'Toole, S.
    Russell, S.
    Li, J.
    Denning, K.
    Aherne, S.
    Ring, M.
    Martin, C.
    Sheppard, B.
    Lao, K.
    Sheils, O.
    Flavin, R. J.
    LABORATORY INVESTIGATION, 2008, 88 : 216A - 216A
  • [30] Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma
    Madore, Jason
    Ren, Fengge
    Filali-Mouhim, Ali
    Sanchez, Lilia
    Koebel, Martin
    Tonin, Patricia N.
    Huntsman, David
    Provencher, Diane M.
    Mes-Masson, Anne-Marie
    JOURNAL OF PATHOLOGY, 2010, 220 (03): : 392 - 400